MediPal Holdings Corporation
7459
Rankning i aktier
#4249
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Aktiekurs
$20.47
Marknadsvärde
$3.73B
Förändring (1 dag)
-0.57%
Förändring (1 år)
23.25%
Land
JP
Handel MediPal Holdings Corporation (7459)
Kategori
Healthcare
P/E-tal för MediPal Holdings Corporation (7459)
P/E-tal per October 2026 TTM: 13.55
Enligt MediPal Holdings Corporation senaste finansiella rapporter och aktiekurs är det aktuella P/E-talet (TTM) 13.55. I slutet av 2024 hade företaget ett P/E-tal på 11.83.
Historik för P/E-tal för MediPal Holdings Corporation från 2005 till 2026
P/E-tal vid slutet av varje år
| År | P/E-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 13.55 | 12.11% |
| 2025 | 12.09 | 2.20% |
| 2024 | 11.83 | 21.17% |
| 2023 | 9.76 | -32.12% |
| 2022 | 14.38 | -22.86% |
| 2021 | 18.64 | 62.38% |
| 2020 | 11.48 | -37.22% |
| 2019 | 18.28 | 29.27% |
| 2018 | 14.14 | 3.79% |
| 2017 | 13.63 | 3.92% |
| 2016 | 13.11 | -12.25% |
| 2015 | 14.94 | 6.79% |
| 2014 | 13.99 | -9.39% |
| 2013 | 15.44 | -28.55% |
| 2012 | 21.62 | -78.66% |
| 2011 | 101.31 | -23.98% |
| 2010 | 133.28 | 563.24% |
| 2009 | 20.09 | 32.62% |
| 2008 | 15.15 | -44.08% |
| 2007 | 27.10 | 41.90% |
| 2006 | 19.09 | -36.81% |
| 2005 | 30.21 | 0.00% |
P/E-tal för liknande företag eller konkurrenter
| Företag | P/E-tal | Skillnad i P/E-tal | Land |
|---|---|---|---|
| 26.02 | 91.98% |
US
|
|
| - | - |
US
|
|
| 34.08 | 151.42% |
US
|
|
| - | - |
US
|
|
| 45.62 | 236.56% |
AU
|
Hur man läser ett P/E-tal
P/E-talet (Price/Earnings) mäter förhållandet mellan ett företags aktiekurs och dess vinst per aktie.
Ett lågt men positivt P/E visar ett företag med hög vinst i förhållande till värderingen och kan vara undervärderat. Ett högt negativt (nära 0) P/E indikerar stora förluster.
Företag med P/E över 30 eller negativt ses ofta som "tillväxtaktier", vilket innebär att investerare förväntar sig tillväxt eller framtida lönsamhet.
Företag med positivt P/E under 10 ses som "värdeaktier" och är redan lönsamma men med begränsad tillväxtpotential.